recombinant Ag85B, recombinant p24, anti HIV-I Integrase monoclonal

PAPERS / MICROBIOLOGY

All listed papers describe results obtained with DIATHEVA's products. Share with us your results sending your next pubblications with our products at info@diatheva.com

MICROBIOLOGY / FOODBORNE PATHOGENS

"Cutting Edge: A Novel Nonoxidative Phagosomal Mechanism Exerted by Cathepsin-D Controls Listeria monocytogenes Intracellular Growth"
The Journal of Immunology July 19, 2011
Rabbit anti-LLO antibody, PN# ANT0006

"The intact structural form of LLO in endosomes cannot protect against listeriosis"
Int J Biochem Mol Biol 2011; 2(3): 207-218
rabbit anti-LLO, PN# ANT0006

“LipA, a Tyrosine and Lipid Phosphatase Involved in the Virulence of Listeria monocytogenes.”
Infect. Immun., (2011); 79: 2489 - 2498.
Rabbit anti-LLO, PN# ANT0007, ANT0016, ANT0034

“Branched-Chain Fatty Acids Promote Listeria monocytogenes Intracellular Infection and Virulence
INFECTION AND IMMUNITY, Nov. 2010, p. 4667–4673”
Rabbit anti-LLO, PN# ANT0006

“Real-Time vs Endpoint Fluorescence Detection of PCR Products: A New Versatile Detection System for Foodborne Pathogen Diagnosis in Multiplex Format."
Journal of Biotechnology, Volume 150, Supplement 1, November 2010, Pages 334-335
MultipathogenFLUO PCR kit - Salmonella spp., L. monocytogenes and E. coli O157, PN# MBK0019

"Efficacy of a Lactococcus lactis ÄpyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes"
Bioengineered Bugs 1:1, 66-74; January/February 2010; © 2010 Landes Bioscience
Rabbit anti-LLO, PN# ANT0006

"Listeriosis: a resurgent foodborne infection"
Clin Microbiol Infect. 2010 Jan; 16(1): 16-23
Human Anti LLO IgG Immunoassay, AKE0007

"The innate immunity role of cathepsin-D is linked to Trp-491 and Trp-492 residues of listeriolysin O"
Mol Microbiol. 2009 May; 72(3): 668-82
rabbit anti-LLO, PN# ANT0006

"Listeriolysin O affects barrier function and induces chloride secretion in HT-29/B6 colon epithelial cells"
Am J Physiol Gastrointest Liver Physiol 296: G1350–G1359, 2009.
Recombinant listeriolysin, PN# REP0007

"Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8+ T cells against Listeria monocytogenes in the murine infection model."
Vaccine, Volume 26, Issue 41, 26 September 2008, Pages 5304-5314
Rabbit anti-LLO, PN# ANT0006

"Preparation of Listeria monocytogenes specimens for molecular detection and identification."
International Journal of Food Microbiology, Volume 122, Issue 3, 20 March 2008, Pages 229-242

"Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000"
Microbial Cell Factories 7:24 2008
Rabbit anti-LLO, PN# ANT0006

“Detection of Listeria monocytogenes using a commercial PCR kit and different DNA extraction methods”
Food Control 18, Issue 9, September 2007, Pages 1137-1142
L.monocytogenes PCR detection kit, PN# MBK0001

"Identification of Novel Listeria monocytogenes Secreted Virulence Factors following Mutational Activation of the Central Virulence Regulator, PrfA†"
INFECTION AND IMMUNITY, Dec. 2007, p. 5886–5897
Recombinant listeriolysin O, PN# REP0007
Rabbit polyclonal anti-LLO, PN# ANT0006

“A combination of diagnostic tools for rapid screening of ovine listeriosis”
Research in Veterinary Science, 81 (2006) 185-189
L.monocytogenes PCR detection kit, PN# MBK0001;
Sheep anti-LLO IgG Immunoassay, PN# AKE0006

"Exploring the role of the CTL epitope region of listeriolysin O in the pathogenesis of Listeria monocytogenes"
Microbiology (2006), 152, 1287–1296
Rabbit anti-LLO, PN# ANT0006

"Liposome-doped nanocomposites as artificial-cell-based biosensors: detection of listeriolysin O"
Biotechnol Prog. 2006 Jan-Feb; 22(1): 32-7
recombinant listeriolysin, PN# REP0007

"Effect of listeriolysin O-loaded rythrocytes on Mycobacterium avium replication within macrophages"
Journal of Antimicrobial Chemotherapy (2004) 53, 863–86
Recombinant listeriolysin O, PN# REP0007

"Listeriolysin O From Listeria Monocytogenes"

MICROBIOLOGY / HIV-1

“HIV-1 Tat Protein Promotes Neuronal Dysfunction through Disruption of MicroRNAs”
The Journal of Biological Chemistry, 286, 41125-41134.
Recombinant Tat clade B, PN# REP0002a - REP0002b

“Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at µ-opioid receptor-expressing glia”
Brain (2011) doi: 10.1093/brain/awr281
Recombinant Tat clade C, PN# REP0030

“Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells”
Journal of Cellular Biochemistry Nov. 2011
Recombinant Tat clade B, PN# REP0002a - REP0002b

“HIV-1 Tat promotes neuronal dysfunction through disruption of microRNAs”
jbc.M111.268466 September 28, 2011
Recombinant Tat clade B, PN# REP0002a - REP0002b

“Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules”
Vaccine. 2011 Aug 2
Recombinant Tat clade B, PN# REP0002b

“Exogenous HIV-1 Nef Upsets the IFN-c-Induced Impairment of Human Intestinal Epithelial Integrity”
PLoS ONE August 2011 | Volume 6 | Issue 8 | e23442
Recombinant HIV-I NEF PN# REP0042

“Recombinant human immunodeficiency virus-1 transactivator of transcription(1-86) allosterically modulates dopamine transporter activity”
Synapse. 2011 Apr 29. doi: 10.1002/syn.20949
Recombinant Tat clade B, PN# REP0002b

“Effects of HIV-1 Nef on Virus Co-receptor Expression and Cytokine Release in Human Bladder, Laryngeal, and Intestinal Epithelial Cell Lines”
VIRAL IMMUNOLOGY Volume 24, Number 3, 2011
Recombinant HIV-I NEF PN# REP0042

“Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking”
Mol Cell Biochem. 2010 Dec; 345(1-2): 105-18
SENZA PN

“ER-ß mediates 17ß-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling”
Synapse. 2010 Nov; 64(11): 829-38
Recombinant Tat clade B, PN# REP0002b

“Hyperdopaminergic tone in HIV-1 protein treated rats and cocaine sensitization”
J Neurochem. 2010 Nov; 115(4): 885-96. doi: 10.1111/j.1471-4159.2010.06968.x
Recombinant Tat clade B, PN# REP0002b

“HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation”
Biochemical and Biophysical Research Communications, Volume 401, Issue 3, 22 October 2010, Pages 429-434
Recombinant tat PN# REP0002

“Induction of anti-Tat neutralizing antibodies by the CyaA vector targeting dendritic cells: Influence of the insertion site and of the delivery of multicopies of the dominant Tat B-cell epitope”
Vaccine, Volume 28, Issue 42, 4 October 2010, Pages 6930-6941
Recombinant tat PN# REP0002

“Impaired plant growth and development caused by human immunodeficiency virus type 1 Tat”
Transgenic Res. 2010 Oct; 19(5): 903-13
Anti HIV-I Tat, PN# ANT0001

“Interactive Comorbidity between Opioid Drug Abuse and HIV-1 Tat: Chronic Exposure Augments Spine Loss and Sublethal Dendritic Pathology in Striatal Neurons”
The American Journal of Pathology, Volume 177, Issue 3, September 2010, Pages 1397-1410
Recombinant tat PN# REP0002

“Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination”
J Cell Physiol. 2010 Sep; 224(3): 702-9
Recombinant Tat clade B, PN# REP0002b

“Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder”
J Neurovirol. 2010 Jul; 16(4): 294-305
Recombinant Tat Clade C, PN# REP0030

“Nuclear Factor-Kappa B Family Member RelB Inhibits Human Immunodeficiency Virus-1 Tat-Induced Tumor Necrosis Factor-Alpha Production”
July 2010 | Volume 5 | Issue 7 | e11875
Recombinant tat PN# REP0002

“HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures”
Neurosci Lett. 2010 May 21; 475(3): 174–178.
Recombinant tat PN# REP0002

“Dose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study”
Hippocampus. 2010 Apr; 20(4): 469-80
Recombinant Tat clade B, PN# REP0002b

“Induction of humoral and enhanced cellular immune responses by novel core–shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration.”
Exp Neurol. 2009 October ; 219(2): 586–590.
Recombinant tat PN# REP0002

“Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice”
Vaccine. 2009 Jul 16; 27(33): 4498-507. Epub 2009 May 28
Recombinant Tat clade B, PN# REP0002b

“Attenuated neurotoxicity of the transactivation-defective HIV-1 Tat protein in hippocampal cell cultures”
Vaccine, Volume 27, Issue 27, 2 June 2009, Pages 3605-3615
Recombinant tat PN# REP0002

“Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain”
J Drug Target. 2009 May; 17(4): 278-85
HIV-I proviral DNA qPCR kit, PN# MBK0016

“The HIV-1 associated protein, Tat1–86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study”
Neuroscience. 2009 April 10; 159(4): 1292–1299.
Recombinant tat PN# REP0002

“In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 Tat-induced alterations in dopamine transmission”
Synapse. 2009 Mar; 63(3): 181-5
Recombinant Tat clade B, PN# REP0002b

“Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons”
Exp Neurol. 2009 February ; 215(2): 253–263.
Recombinant tat PN# REP0002

“HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium”
Blood 2009 114: 3335-3342
Anti-Tat-FITC antibody, PN# ANT0005

“Differential Effects of HIV Type 1 Clade B and Clade C Tat Protein on Expression of Proinflammatory and Antiinflammatory Cytokines by Primary Monocytes”
AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 25, Number 7, 691-699 - 2009
Recombinant tat clade C PN# REP0030

“Differential Regulation of Indoleamine-2,3-Dioxygenase (IDO) by HIV Type 1 Clade B and C Tat Protein”
AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 25, Number 3, 2009
Recombinant tat clade C PN# REP0030

“HIV-1 Tat Protein-Induced Rapid and Reversible Decrease in [3H]Dopamine Uptake: Dissociation of [3H]Dopamine Uptake and [3H]2β-Carbomethoxy-3-β-(4-fluorophenyl)tropane (WIN 35,428) Binding in Rat Striatal Synaptosomes”
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 329, No. 3:1071–1083, 2009
Recombinant Tat clade B, PN# REP0002b;
RecombinantTat Cys22, PN# REP0033

“Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons ”
NeuroToxicology, Volume 29, Issue 6, November 2008, Pages 971-977
Recombinant Tat clade B, PN# REP0002b

“Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 ΔV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin”
Vaccine, Volume 26, Issue 9, 26 February 2008, Pages 1214-1227
Recombinant Tat clade B, PN# REP0002b

“The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS”
Vaccine, Volume 26, Issue 5, 30 January 2008, Pages 727-737
Recombinant Tat clade B, PN# REP0002b

“Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes”
Pharm Res. 2007 Oct; 24(10): 1870-82. Epub 2007 May 3
Recombinant Tat clade B, PN# REP0002b

“Administration of Fludarabine-Loaded Autologous Red Blood Cells in Simian Immunodeficiency Virus-Infected Sooty Mangabeys Depletes pSTAT-1-Expressing Macrophages and Delays the Rebound of Viremia after Suspension of Antiretroviral Therapy”
JOURNAL OF VIROLOGY, Nov. 2006, p. 10335–10345
anti-p24, PN# ANT0020

“Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles”
Rabbit Anti HIV-I Tat - Affinity Purified, PN# ANT0041

“Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS”
Recombinant Tat Clade C, PN# REP0030

MICROBIOLOGY / M. PARATUBERCOLOSIS

“Recombinant BCG coexpressing Ag85B, CFP10, and interleukin-12 induces multifunctional Th1 and memory T cells in mice”
APMIS, 2011
Recombinant Ag85B, PN# REP0025

“New alternative vaccine component against mycobacterium tuberculosis--heat shock protein 16.3 or its T-cell epitope”
Scand J Immunol. 2009 Nov; 70(5): 465-74
Recombinant Ag85B, PN# REP0025

“Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis”
DNA Cell Biol. 2008 Apr; 27(4): 199-207
Recombinant Ag85B, PN# REP0025

MORE PAPERS

BROCHURES and APPLICATION GUIDES